Rofecoxib in the acute treatment of migraine: A randomized controlled clinical trial

Headache

Volumn 46, Issue 2, 2006, Pages 264-275

  Saper, Joel ^a   Dahlof, Carl ^b   So, Yuen ^c   Tfelt Hansen, Peer ^d   Malbecq, William ^e   Loeys, Thomas ^e   Barraclough, Eleathea ^f   Klipfel, Meghan ^f   Lines, Christopher ^f   Visser, Hester ^f   Reines, Scott ^f   Yuen, Eric ^f  

^a Michigan Head Pain and Neurological Institute   (United States)

^b Gothenburg Migraine Clinic   (Sweden)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e Merck Sharp and Dohme   (Belgium)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Ibuprofen; Migraine; NSAIDS; Randomized controlled trial; Rofecoxib

Indexed keywords

IBUPROFEN; PLACEBO; ROFECOXIB;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FACE EDEMA; FEMALE; HERPES SIMPLEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SOMNOLENCE; TIME; TONGUE EDEMA; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; XEROSTOMIA;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; LACTONES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; SEROTONIN AGONISTS; SULFONES; TREATMENT OUTCOME;

EID: 33645075176     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00334.x     Document Type: Article

References (23)

1. Matchar DB Young WB Rosenberg JH et al. 2000 Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks Available at Accessed February 12, 2004
2. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2000 55 754 762
3. MacDonald TM Morant SV Robinson GC et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study BMJ 1997 315 1333 1337
4. Langman MJ Jensen DM Watson DJ et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs JAMA 1999 282 1929 1933
5. Lisse JR Perlman M Johansson G et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial Ann Intern Med 2003 139 539 546
6. Laine L Connors LG Reicin A et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use Gastroenterology 2003 124 288 292
7. Watson DJ Harper SE Zhao PL Bolognese JA Simon TJ Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs Med Gen Med 2001 3 6
8. Hawkey CJ Jackson L Harper SE Simon TJ Mortensen E Lines CR Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans Aliment Pharmacol Ther 2001 15 1 9
9. Watson DJ Harper SE Zhao PL Quan H Bolognese JA Simon TJ Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis Arch Intern Med 2000 160 2998 3003
10. Matheson AJ Figgitt DP Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis Drugs 2001 61 833 865
11. Chang DJ Bird SB Bohidar NR Dobbins TW Geba GP Superior analgesic efficacy of rofecoxib compared with codeine/acetaminophen in two acute pain studies utilizing the dental-impaction model Arthritis Rheum 2001 44 9 suppl S124
12. Chang DJ Desjardins PJ Bird SR et al. Comparison of rofecoxib and multidose oxycodone/acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial Curr Med Res Open 2004 20 939 949
13. Silberstein S Tepper S Brandes J et al. Randomized, placebo-controlled trial of rofecoxib for the acute treatment of migraine Neurology 2004 62 1552 1557
14. Kellstein DE Lipton RB Geetha R et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, doube-blind, placebo-controlled, dose-ranging study Cephalalgia 2000 20 233 243
15. Codiposti JR Prior MJ Fu M Harte CM Nelson EB Efficacy of nonprescription doses of ibuprofen for treating migraine headaches. A randomized controlled trial Headache 2001 41 665 679
16. Headache Classification Committee of the International Headache Society Classification and diagnostic critieria for headache disorders, cranial neuralgias and facial pain Cephalalgia 1988 8 suppl 7 1 96
17. Hartmaier SL Santanello NC Epstein RS Silberstein SD Development of a brief 24-hour migraine-specific quality of life questionnaire Headache 1995 35 320 329
18. Santanello NC Hartmaier SL Epstein RS Silberstein SD Validation of a new quality of life questionnaire for acute migraine headache Headache 1995 35 330 337
19. Adelman JU Lipton RB Ferrari MD et al. Comparison of rizatriptan and other triptans on stringent measures of efficacy Neurology 2001 57 1377 1383
20. Ferrari MD Loder E McCarroll KA Lines CR Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials Cephalalgia 2001 21 129 136
21. Morrison BW Christensen S Yuan W Brown J Amlani S Seidenberg B Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial Clin Ther 1999 21 943 953
22. Bresalier RS Sandler RS Quan H et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial New Engl J Med 2005 352 1092 1102
23. U.S. Food and Drug Administration Memorandum: analysis and recommendations for Agency action regarding nonsteroidal anti-inflammatory drugs and cardiovascular risk. April 6, 2005 Available at